Health & Fitness
Health and Fitness
Health and Fitness
Mon, April 23, 2012Sun, April 22, 2012Sat, April 21, 2012Fri, April 20, 2012Thu, April 19, 2012Wed, April 18, 2012Tue, April 17, 2012Mon, April 16, 2012Sun, April 15, 2012Sat, April 14, 2012Fri, April 13, 2012Thu, April 12, 2012Wed, April 11, 2012Tue, April 10, 2012Mon, April 9, 2012MELA Sciences to Release First Quarter Financial Results and Host Conference Call on Thursday, May 3, 2012
Published in Health and Fitness on Monday, April 16th 2012 at 13:35 GMT by Market Wire
April 16, 2012 16:30 ET
MELA Sciences to Release First Quarter Financial Results and Host Conference Call on Thursday, May 3, 2012
IRVINGTON, NY--(Marketwire - Apr 16, 2012) - [ MELA Sciences, Inc. ] (
Date: Thursday, May 3, 2012
Time: 4:30 PM ET
To participate in the teleconference, please dial:
Domestic toll-free: (888) 437-9481
International: (719) 325-2337
Participant Code: 5102483
To listen via live webcast, please go to the investor relations section of the MELA Sciences website at [ http://www.melasciences.com ] approximately 10 minutes prior to the teleconference start time. If you are unable to participate during the live conference call and webcast, the conference call audio cast will be archived and available for replay for approximately 90 days.
About MELA Sciences, Inc.
MELA Sciences is a medical device company focused on the commercialization of its flagship product, MelaFind®, and its further design and development. MelaFind is a non-invasive tool to provide additional information to dermatologists during melanoma skin examinations. The device uses light from visible to near-infrared wavelengths to evaluate skin lesions up to 2.5 mm beneath the skin. The device provides information on a lesion's level of morphologic disorganization to provide additional objective information that may be used by dermatologists in the biopsy decision-making process. MelaFind has been approved by the US Food and Drug Administration for use in the US. In addition, MelaFind has received CE Mark approval and is approved for use in the European Union.
For more information on MELA Sciences, visit [ www.melasciences.com ].
